ALBERT B. SABIN VACCINE INSTITUTE, INC. (THE): $224M Department of Health and Human Services Contract
Summary
The Department of Health and Human Services awarded a $224M definitive contract to the Albert B. Sabin Vaccine Institute, a private entity, for Marburg virus advanced R&D and preparedness. As the recipient is not publicly traded, no direct stock impact is identified, but the contract signals increased government focus on pandemic preparedness, which may benefit the broader healthcare sector.
See which stocks are affected
Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.
Already have an account? Log in
Key Takeaways
- 1.The $224M contract to a private entity does not directly impact any publicly traded company's revenue.
- 2.The contract underscores government prioritization of Marburg virus preparedness, which may indirectly benefit vaccine-related ETFs or sector funds.
- 3.Investors should monitor future subcontract awards or licensing deals that could involve public companies.
Market Implications
The contract is a positive signal for the healthcare sector's pandemic preparedness subsector, but with no public company directly benefiting, the market impact is muted. Investors in vaccine-related stocks should watch for any subcontracting announcements or technology transfer agreements that could involve public firms like $DVAX or $NVAX, though no such links are confirmed.
Full Analysis
- The contract: The Office of Assistant Secretary for Preparedness and Response awarded a $224M definitive contract to the Albert B. Sabin Vaccine Institute for the Strategic Marburg Advanced Research and Development, Preparedness, Registration, Evaluation and Procurement (SMART-PREP) program. The contract runs from May 2026 to April 2036, indicating a long-term commitment to Marburg virus countermeasures. 2) The recipient is a private, non-profit vaccine research institute, so no publicly traded parent company exists. This contract does not directly flow to any public company's revenue. 3) Related legislation: While no specific bill directly authorizes this contract, the broader healthcare focus aligns with bills like HR8324 (Great American Healthcare Plan, bullish healthcare) and HR8857 (bullish healthcare on drug pricing). These bills signal a supportive legislative environment for vaccine and preparedness funding. 4) Supply chain: Potential subcontractors could include contract research organizations (CROs) and manufacturing partners, but without public disclosure, specific tickers cannot be reliably named. 5) Historical pattern: Large government contracts for pandemic preparedness often lead to follow-on procurement and stockpiling contracts, but the private nature of the recipient limits direct market impact.
Connected Signals
Matched on shared policy language across AI analyses, with ticker & timing weight
Great American Healthcare Plan
To amend title XI of the Social Security Act to adjust which engineered cyclic peptides are qualifying single source drugs for purposes of the Drug Price Negotiation Program.
DELL FEDERAL SYSTEMS L.P: $1.0B Department of Veterans Affairs Contract
OPTUM PUBLIC SECTOR SOLUTIONS, INC.: $598M Department of Veterans Affairs Contract
OPTUM PUBLIC SECTOR SOLUTIONS, INC.: $641M Department of Veterans Affairs Contract
TRIWEST HEALTHCARE ALLIANCE CORP: $903M Department of Veterans Affairs Contract
TRIWEST HEALTHCARE ALLIANCE CORP: $874M Department of Veterans Affairs Contract
OPTUM PUBLIC SECTOR SOLUTIONS, INC.: $773M Department of Veterans Affairs Contract
Related Presidential Actions
Executive orders & memoranda affecting the same sectors or companies
Advancing Regenerative Agriculture and Strengthening American Farm Resilience
This executive order directs the EPA, USDA, and HHS to prioritize registration of alternative pesticides, expedite cumulative exposure research, and maximize funding for a regenerative agriculture pilot program, while creating public-private partnerships to expand adoption of conservation farming practices. The order specifically instructs the EPA Administrator to speed up registration actions for substances that can replace older active ingredients, and requires HHS to issue a grand prize challenge for cumulative chemical exposure evaluation technologies.
Implementing Schedule Policy/Career in the Excepted Service
This executive order expands the Schedule Policy/Career excepted service category, transferring certain federal positions from competitive service to at-will employment to facilitate removal for poor performance or misconduct. It directs agency heads to petition for reclassification of policy-influencing roles, mandates performance bonus pools for these employees, and amends civil service rules to exempt them from standard adverse action procedures.
Realigning United States Core Childhood Vaccine Recommendations with Best Practices from Peer, Developed Countries
This executive order directs the CDC and ACIP to review and potentially update the U.S. childhood vaccine schedule to align with recommendations from peer developed countries, which recommend fewer vaccines. It maintains insurance coverage for all currently available vaccines without cost sharing and emphasizes protecting religious liberty and parental authority.
Contract Details
Recipient
ALBERT B. SABIN VACCINE INSTITUTE, INC. (THE)
Award Amount
$223,798,184
Awarding Agency
Department of Health and Human Services
Sub-Agency
Office of Assistant Secretary for Preparedness and Response
Contract Type
DEFINITIVE CONTRACT
Related Bills
Free — no credit card
Get the next market-moving signal before the news does
HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.
Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.
Free forever plan · No credit card · Unsubscribe in one click
Want the live terminal too? Create a free account →